Revista Brasileira de Ginecologia e Obstetricia is a renowned academic journal based in Brazil, published by GEORG THIEME VERLAG KG, dedicated to advancing research in the fields of gynecology and obstetrics. With an Open Access policy since 1998, this journal ensures that critical findings and insights remain accessible to a global audience, fostering collaboration and knowledge sharing among healthcare professionals and researchers. The journal has maintained a respectable position within its field, currently ranked Q3 in Obstetrics and Gynecology according to the 2023 category quartiles, and holds a Scopus rank of 122 out of 209, placing it in the 41st percentile. Covering a wide array of topics pertinent to women's health, the Revista Brasileira de Ginecologia e Obstetricia serves as a vital platform for disseminating new research, clinical practices, and reviews, contributing to the enhanced understanding and treatment of gynecological and obstetrical conditions. The journal not only supports academic rigor but also empowers professionals and students in their pursuit of excellence in women's health.

Human Reproduction Open, published by Oxford University Press, is a prestigious open-access journal dedicated to advancing the field of reproductive health and medicine since its inception in 2017. With an E-ISSN of 2399-3529, the journal provides a vital platform for researchers, clinicians, and academics to disseminate innovative findings in obstetrics, gynecology, and reproductive medicine. It is recognized for its impactful contributions, holding an impressive rank of #3 out of 209 in Medicine - Obstetrics and Gynecology, #2 out of 90 in Medicine - Reproductive Medicine, and #1 out of 21 in Medicine - Embryology, placing it in the top percentiles of its respective categories. The open-access model ensures that research is freely accessible, fostering collaboration and knowledge sharing among professionals and students alike. With a commitment to high-quality, peer-reviewed publications, Human Reproduction Open plays a crucial role in shaping the future of reproductive health research and practice, serving as an essential resource for those dedicated to improving outcomes in this dynamic field.

Human Fertility, published by Taylor & Francis Ltd, is a key academic journal that serves the dynamic fields of medicine, obstetrics and gynecology, and reproductive medicine. Established in 1998 and with converged content extending to 2024, the journal holds a notable Q2 ranking in its respective categories, highlighting its influence and scholarly contributions to current research and practice. With an ISSN of 1464-7273 and an E-ISSN of 1742-8149, it rigorously disseminates studies, reviews, and advancements in human fertility, particularly emphasizing evidence-based practices and innovative techniques. Despite its traditional subscription model, the journal remains vital for researchers, healthcare professionals, and students seeking to foster advancements in reproductive health. Its articles are pivotal in addressing the multifaceted challenges faced in reproductive health and guiding future research trajectories.

Clinical and Experimental Reproductive Medicine (CERM) is a premier journal dedicated to advancing the field of reproductive medicine. Published by the Korean Society of Reproductive Medicine, it aims to disseminate high-quality research and innovative clinical practices in reproductive health and medicine. With its Q3 ranking in reproductive medicine for 2023, CERM is positioned as a significant resource for researchers and practitioners seeking to stay current with the latest developments and findings in the field. Since its inception in 2011, CERM has provided a vital platform for original research articles, review papers, and case studies that cover a range of topics, including fertility treatments, reproductive endocrinology, and embryology. Researchers benefit from its accessibility, inspiring new insights and evidence-based approaches to clinical practices. Based in South Korea, its rigorous peer-reviewed publication process ensures that all contributions meet high academic standards, making it an invaluable asset for anyone engaged in reproductive health research or practice.

Fertility and Sterility is a prestigious peer-reviewed journal dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier Science Inc, this journal has been a cornerstone of scientific discourse since its inception in 1950 and is set to continue its influential coverage of cutting-edge research until 2024. Boasting an impressive impact factor, Fertility and Sterility is ranked among the top-tier journals in its category, holding Q1 status in both Obstetrics and Gynecology and Reproductive Medicine. With Scopus rankings placing it in the 97th and 96th percentiles respectively, the publication serves as a vital resource for researchers, clinicians, and students who seek to advance their understanding of fertility issues and reproductive health. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and innovative solutions to the complex challenges in reproduction, empowering professionals and scholars to make meaningful contributions in their fields.

Nature Reviews Urology, published by NATURE PORTFOLIO, stands as a leading journal in the field of urology, showcasing cutting-edge research and reviews that address the complexities and advancements within this dynamic medical specialty. With a 2023 impact factor that places it firmly in the Q1 quartile of urology journals, it ranks impressively within the top 3 out of 120 in Scopus, highlighting its critical role in disseminating significant academic findings. As a premier source of scholarly information, this journal aims to provide urology professionals, researchers, and students with comprehensive insights into the latest clinical practices, therapeutic developments, and technological innovations, promoting a deeper understanding of urological conditions. The journal also ensures accessibility to its articles, demonstrating a commitment to the open dissemination of knowledge essential for advancing urology research and practice.

The International Journal of Sexual Health, published by Routledge Journals, Taylor & Francis Ltd, serves as a crucial platform for the dissemination of cutting-edge research in the multifaceted field of sexual health. With an ISSN of 1931-7611 and an E-ISSN of 1931-762X, this journal has rapidly established itself as a key publication since its inception in 2007, boasting an impressive trajectory leading to its anticipated convergence into 2024. The journal excels in various domains, achieving a Q1 ranking in Gender Studies and securing Q2 placements in Dermatology, Public Health, Environmental and Occupational Health, Reproductive Medicine, and Social Psychology for 2023, reflecting its broad interdisciplinary influence. Furthermore, the Scopus rankings position it favorably within its respective categories, confirming its relevance and academic rigor. Although the journal operates under a subscription model, it remains dedicated to illuminating pressing issues in sexual health, making it indispensable for researchers, professionals, and students dedicated to advancing knowledge in this essential area of study.

The International Journal of Reproductive Biomedicine, an esteemed publication by SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, serves as a pivotal platform in the fields of obstetrics and gynecology as well as reproductive medicine. Established in 2011 and transitioning to an open access model in 2015, this journal facilitates the dissemination of innovative research and critical findings to a global audience, particularly focusing on advancements in reproductive health and biomedicine. With an impact factor reflective of its commitment to high-quality scientific inquiry, the journal has achieved a notable ranking of Q3 in both its categories for 2023, contributing to its growing influence within the academic community. Researchers and professionals benefit from its broad scope, which encompasses a range of topics essential to reproductive health, thus fostering a rich exchange of knowledge. The journal's accessibility allows students and professionals alike to engage with the latest findings and contribute to ongoing discussions within this vital field of study.

HUMAN REPRODUCTION is a prestigious academic journal published by Oxford University Press, dedicated to advancing the field of reproductive medicine. With an impressive impact factor highlighting its significance, the journal ranks in the top quartile (Q1) for Obstetrics and Gynecology, Rehabilitation, and Reproductive Medicine, showcasing its crucial role in disseminating high-quality research. Founded in 1986, it has become a key resource for researchers, practitioners, and students interested in cutting-edge developments and innovative practices in human reproduction. Despite not currently offering open access, the journal continues to publish a wealth of peer-reviewed articles that contribute substantially to clinical knowledge and practice. With Scopus rankings placing it among the top journals in its categories, HUMAN REPRODUCTION remains an essential platform for discussion and dissemination of vital findings impacting reproductive health globally.

Revista Internacional de Andrologia, published by Elsevier España SLU, is a pivotal academic journal advancing the field of andrology, particularly focusing on reproductive medicine and urology. With an ISSN of 1698-031X and recognized as a reputable source within the medical community, this journal holds a Q3 ranking in both Reproductive Medicine and Urology as of 2023, reflecting its significant contribution to the field. Researchers and professionals are encouraged to engage with a diverse range of articles published annually, offering insights into current trends, innovative methodologies, and emerging challenges. Although the journal is not open access, it is an essential resource for those seeking to stay at the forefront of research and practice in andrology, making it a valuable tool for academics and clinicians alike. As the journal progresses through its converged years from 2005 to 2024, it remains committed to fostering collaboration and knowledge dissemination within the global medical community.